Abbott Laboratories (TICKER: ABT) Benchmark And Performance Data

there are 11 of samples in the benchmark for Abbott Laboratories in year 2022 in 2022. The total inventory for Abbott Laboratories was $5,157,000,000.00 in 2021. The total inventory for Abbott Laboratories was $5,012,000,000.00 in 2020. The total inventory for Abbott Laboratories was $4,316,000,000.00 in 2019. The total inventory for Abbott Laboratories was $3,796,000,000.00 in 2018. The total inventory for Abbott Laboratories was $3,793,000,000.00 in 2012. The total inventory for Abbott Laboratories was $3,601,000,000.00 in 2017. The total inventory for Abbott Laboratories was $2,693,000,000.00 in 2013. The total inventory for Abbott Laboratories was $2,643,000,000.00 in 2014. The total inventory for Abbott Laboratories was $2,599,000,000.00 in 2015. The total inventory for Abbott Laboratories was $2,434,000,000.00 in 2016. The sales, general, and administrative (SGA) for Abbott Laboratories was $9,765,000,000.00 in 2019. The sales, general, and administrative (SGA) for Abbott Laboratories was $9,744,000,000.00 in 2018. The sales, general, and administrative (SGA) for Abbott Laboratories was $9,696,000,000.00 in 2020. The sales, general, and administrative (SGA) for Abbott Laboratories was $9,182,000,000.00 in 2017. The sales, general, and administrative (SGA) for Abbott Laboratories was $6,785,000,000.00 in 2015. The sales, general, and administrative (SGA) for Abbott Laboratories was $6,736,000,000.00 in 2016. The sales, general, and administrative (SGA) for Abbott Laboratories was $6,735,000,000.00 in 2012. The sales, general, and administrative (SGA) for Abbott Laboratories was $6,530,000,000.00 in 2014. The sales, general, and administrative (SGA) for Abbott Laboratories was $6,372,000,000.00 in 2013. The sales, general, and administrative (SGA) for Abbott Laboratories was $11,324,000,000.00 in 2021. The sales, general, and administrative (SGA) for Abbott Laboratories was $$11,248,000,000 in 2022. The revenue volatility for Abbott Laboratories was 15.09% in 2022. The market capitalization for Abbott Laboratories was $248,276,927,842.00 in 2014. The market capitalization for Abbott Laboratories was $208,887,739,647.00 in 2013. The market capitalization for Abbott Laboratories was $207,241,529,326.00 in 2015. The market capitalization for Abbott Laboratories was $205,522,715,269.00 in 2012. The market capitalization for Abbott Laboratories was $191,426,964,976.00 in 2018. The market capitalization for Abbott Laboratories was $190,270,025,076.00 in 2016. The market capitalization for Abbott Laboratories was $189,188,726,979.00 in 2020. The market capitalization for Abbott Laboratories was $176,085,752,866.00 in 2019. The market capitalization for Abbott Laboratories was $168,708,198,662.00 in 2017. The market capitalization for Abbott Laboratories was $168,069,420,363.00 in 2021. The market capitalization for Abbott Laboratories was $$194,630,000,000 in 2022. The gross revenue for Abbott Laboratories was $43,075,000,000.00 in 2021. The gross revenue for Abbott Laboratories was $34,608,000,000.00 in 2020. The gross revenue for Abbott Laboratories was $31,904,000,000.00 in 2019. The gross revenue for Abbott Laboratories was $30,578,000,000.00 in 2018. The gross revenue for Abbott Laboratories was $27,390,000,000.00 in 2017. The gross revenue for Abbott Laboratories was $20,853,000,000.00 in 2016. The gross revenue for Abbott Laboratories was $20,405,000,000.00 in 2015. The gross revenue for Abbott Laboratories was $20,247,000,000.00 in 2014. The gross revenue for Abbott Laboratories was $19,657,000,000.00 in 2013. The gross revenue for Abbott Laboratories was $19,050,000,000.00 in 2012. The gross revenue for Abbott Laboratories was $$43,653,000,000 in 2022. The gross margin for Abbott Laboratories was $19.16% in 2022. The days sales outstanding for Abbott Laboratories was 53 days in 2022. The days payable outstanding for Abbott Laboratories was 86 days in 2022. The days of inventory for Abbott Laboratories was $108 in 2022. The cost of goods sold (COGS) for Abbott Laboratories was 43.85% in 2022. The cost of goods sold (COGS) for Abbott Laboratories was $9,218,000,000.00 in 2014. The cost of goods sold (COGS) for Abbott Laboratories was $9,193,000,000.00 in 2013. The cost of goods sold (COGS) for Abbott Laboratories was $9,094,000,000.00 in 2016. The cost of goods sold (COGS) for Abbott Laboratories was $8,899,000,000.00 in 2012. The cost of goods sold (COGS) for Abbott Laboratories was $8,747,000,000.00 in 2015. The cost of goods sold (COGS) for Abbott Laboratories was $18,537,000,000.00 in 2021. The cost of goods sold (COGS) for Abbott Laboratories was $15,003,000,000.00 in 2020. The cost of goods sold (COGS) for Abbott Laboratories was $13,231,000,000.00 in 2019. The cost of goods sold (COGS) for Abbott Laboratories was $12,706,000,000.00 in 2018. The cost of goods sold (COGS) for Abbott Laboratories was $12,409,000,000.00 in 2017. The cost of goods sold (COGS) for Abbott Laboratories was $$19,142,000,000 in 2022. The cash to cash cycle time for Abbott Laboratories was 75 in 2022. The annual percentage growth rate of Abbott Laboratories was -0.01% in 2022. Abbott Laboratories in its benchmark peer group, had rank 8 for cost of goods sold as a percent of revenue in 2022. Abbott Laboratories in its benchmark peer group, had rank 4 days for days sales outstanding in 2022. Abbott Laboratories in its benchmark peer group, had rank 4 days for days of inventory in 2022. Abbott Laboratories in its benchmark peer group, had rank 3 for sales growth in 2022. Abbott Laboratories in its benchmark peer group, had rank 2 for cash to cash cycle time in 2022. Abbott Laboratories in its benchmark peer group, had rank 1 for gross revenue in 2022. Abbott Laboratories headquarters region is Central. Abbott Laboratories has ticker symbol ABT. Abbott Laboratories has the following profile: Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.. Abbott Laboratories has primary indstury Medical Devices. Abbott Laboratories had a $$0 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Abbott Laboratories had Abbott Laboratories, and QuidelOrtho, and Zimmer Biomet, and Edwards Lifesciences, and Bio-Rad Laboratories, and Boston Scientific, and Align Technology, and Stryker, and AdaptHealth, and Bruker, and DexCom benchmark peer companies for its SIC code in 2022. Abbott Laboratories had 9 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Abbott Laboratories had 6.61% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Abbott Laboratories had 14 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Abbott Laboratories had 115,000 number of employees in 2022. Abbott Laboratories had 10.84% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Abbott Laboratories had 1.76% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Abbott Laboratories had 0.05% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Abbott Laboratories had 0 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Abbott Laboratories can reduce overall cost by $$5,832,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Abbott Laboratories can reduce inventory with practices including SKU Reduction in 2022. Abbott Laboratories can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Abbott Laboratories can reduce inventory with practices including Forecast Accuracy in 2022. Abbott Laboratories can reduce inventory with practices including Demand Shaping in 2022. Abbott Laboratories can reduce days sales outstanding with practices including in 2022. Abbott Laboratories can increase sales revenue by $$0 improving sales performance to next benchmark tier in 2022. Abbott Laboratories can increase revenue growth by $$24,000,000 by improving growth performance to next benchmark tier in 2022. Abbott Laboratories can increase overall revenue by $$24,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Abbott Laboratories can increase days payables outstanding with practices including in 2022. Abbott Laboratories can increase days payables outstanding by $0 days by increasing days payables outstanding to next benchmark tier in 2022. Abbott Laboratories can improve total financial performance by $$8,607,000,000 by improving revenue, costs, and working capital in 2022. Abbott Laboratories can decrease overall working capital by $$2,751,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Abbott Laboratories can decrease inventory days by $1,674,000,000 days by reducing inventory days to next benchmark tier in 2022. Abbott Laboratories can decrease days sales outstanding by $1,076,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Abbott Laboratories can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Abbott Laboratories can accelerate revenue growth practices including Pricing Optimization in 2022. Abbott Laboratories can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 94 days was the measured superior or top ten performance level for days of inventory in Abbott Laboratories's peer group in 2022. 9.89% was the measured superior or top ten performance level for sales volatility in Abbott Laboratories's peer group in 2022. 75 days was the measured superior or top ten performance level for cash to cash cycle time in Abbott Laboratories's peer group in 2022. 60 days was the measured parity or middle performance level for days sales outstanding in Abbott Laboratories's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in Abbott Laboratories's peer group in 2022. 44 days was the measured superior or top ten performance level for days sales outstanding in Abbott Laboratories's peer group in 2022. 37.24% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Abbott Laboratories's peer group in 2022. 31.56% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Abbott Laboratories's peer group in 2022. 30.00% was the measured superior or top ten performance level for gross margin in Abbott Laboratories's peer group in 2022. 29.10% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Abbott Laboratories's peer group in 2022. 159 days was the measured parity or middle performance level for days of inventory in Abbott Laboratories's peer group in 2022. 138 days was the measured parity or middle performance level for cash to cash cycle time in Abbott Laboratories's peer group in 2022. 13.32% was the measured parity or middle performance level for sales volatility in Abbott Laboratories's peer group in 2022. 119 days was the measured advantage or top third performance level for cash to cash cycle time in Abbott Laboratories's peer group in 2022. 11.40% was the measured advantage or top third performance level for sales volatility in Abbott Laboratories's peer group in 2022. 108 days was the measured advantage or top third performance level for days of inventory in Abbott Laboratories's peer group in 2022. 0.04% was the measured superior or top ten performance level for sales growth in Abbott Laboratories's peer group in 2022. -0.05% was the measured parity or middle performance level for sales growth in Abbott Laboratories's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in Abbott Laboratories's peer group in 2022. $18.02% was the measured advantage or top third performance level for gross margin in Abbott Laboratories's peer group in 2022. $17.18% was the measured parity or middle performance level for gross margin in Abbott Laboratories's peer group in 2022. $$6,940,000,000 was the measured advantage or top third performance level for gross revenue in Abbott Laboratories's peer group. $$3,735,000,000 was the measured parity or middle performance level for gross revenue in Abbott Laboratories's peer group in 2022. $$18,449,000,000 was the measured superior or top ten performance level for gross revenue in Abbott Laboratories's peer group in 2022.